LBR and cancer: In particular, our data demonstrate that reduced expression of miR-222 or overexpression of LBR in CAFs greatly reduces their ability to promote aggressive behaviours in cancer cells, supporting the proposal that CAF phenotypes are not fixed and could be normalised therapeutically.